American Society of Plastic Surgeons Welcomes Allergan as Sapphire Sponsor of Plastic Surgery The Meeting
ARLINGTON HEIGHTS, IL – The American Society of Plastic Surgeons (ASPS) is proud to recognize Allergan as a Sapphire sponsor of Plastic Surgery The Meeting, the specialty's largest scientific conference. Hosted Sept. 20-23 in San Diego, California, The Meeting is the leading educational and networking event of the year for both plastic surgeons in the United States and around the world.
"Allergan's commitment to research and development of pharmaceuticals and biologic products have improved the quality of life for patients around the world," said Alan Matarasso, MD, president of the American Society of Plastic Surgeons. "They are a trusted partner in advancing patient safety and quality outcomes for our patients."
Bringing together the best and brightest surgeons in the specialty, The Meeting is a platform for the world's largest gathering of plastic and reconstructive surgeons to share their expertise with colleagues from nearly 50 nations.
The ASPS Sapphire sponsorship program provides industry partners with increased visibility and greater recognition for their support at Plastic Surgery The Meeting. Partnering with ASPS provides unprecedented opportunities to communicate and engage with aesthetic and reconstructive plastic surgeons from around the world.
For more information, visit the Plastic Surgery The Meeting website.
The American Society of Plastic Surgeons (ASPS) is the largest organization of board-certified plastic surgeons in the world. Representing more than 11,000 physician members worldwide, the society is recognized as a leading authority and information source on cosmetic and reconstructive plastic surgery. ASPS comprises more than 92 percent of all board-certified plastic surgeons in the United States. Founded in 1931, the society represents physicians certified by The American Board of Plastic Surgery or The Royal College of Physicians and Surgeons of Canada.
Allergan plc, headquartered in Dublin, Ireland, is a bold, global pharmaceutical company and a leader in a new industry model – Growth Pharma. Allergan is focused on developing, manufacturing and commercializing branded pharmaceuticals, devices and biologic products for patients around the world.
Allergan markets a portfolio of leading brands and best-in-class products for the central nervous system, eye care, medical aesthetics and dermatology, gastroenterology, women's health, urology and anti-infective therapeutic categories.